Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin

被引:31
作者
Palepou, MFI
Johnson, AP
Cookson, BD
Beattie, H
Charlett, A
Woodford, N
机构
[1] Cent Publ Hlth Lab, Antibiot Reference Unit, Lab Hosp Infect, London NW9 5HT, England
[2] PHLS, Stat Unit, London NW9 5HT, England
关键词
D O I
10.1093/jac/42.5.577
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The susceptibilities to mupirocin of 102 selected clinical isolates of Staphylococcus aureus and of control strain S. aureus NCTC 6571 were determined by disc diffusion (using discs containing 5, 15, 25, 30, 50 and 200 mu g Of mupirocin) and Etest and the results were compared with MICs determined using an agar incorporation method. On the basis of agar incorporation MICs, 42 isolates were sensitive to mupirocin (MIC less than or equal to 4 mg/L), 39 showed low-level resistance (MICs = 8-128 mg/L) and 22 were highly resistant (MICs greater than or equal to 256 mg/L) and contained the mupA resistance gene. Using Stokes' criteria, none of the discs used gave major errors (sensitive isolates classified as highly resistant) or very major errors (highly resistant isolates classified as sensitive) in assigning a category of susceptibility, but minor errors (a difference of one category) were noted with all strengths. The best correlation with agar incorporation MIC was obtained with 25 mu g mupirocin discs, which classified correctly 98 (95%) isolates, while worse correlations were noted with 5 mu g and 200 lug discs which are the only types currently available commercially, for which there were 47 and 30 minor errors, respectively. The MICs found by Etest were the same as, or lower than, those determined by agar incorporation. Etests classified correctly all 42 mupirocin-sensitive isolates, 19 (49%) low-level resistant isolates and 16 (73%) highly resistant isolates. Two isolates that contained the mupA gene and showed agar incorporation MICs of 256 mg/L and 512 mg/L were not classified as highly resistant by any of the diffusion methods used. Agar incorporation MIC determination, possibly supported by detection of the mupA gene, offers the most effective means of identifying high-level mupirocin resistance in S. aureus, although the Etest also proved to be reproducible. However, we conclude that 25 Icg discs warrant further evaluation for possible use in clinical laboratories, as they appear to be more reliable than the discs currently available.
引用
收藏
页码:577 / 583
页数:7
相关论文
共 15 条
[1]   Detection of the mec-A gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance [J].
Bignardi, GE ;
Woodford, N ;
Chapman, A ;
Johnson, AP ;
Speller, DCE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (01) :53-63
[2]  
BRADLEY SF, 1995, INFECT CONT HOSP EP, V16, P354
[3]  
CASEWELL MW, 1997, ANTIBIOT CHEMOTHER, P394
[4]   MUPIROCIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].
COOKSON, B ;
FARRELLY, H ;
PALEPOU, MF ;
GEORGE, R .
LANCET, 1992, 339 (8793) :625-625
[5]   The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice [J].
Cookson, BD .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) :11-18
[6]   AMANTADINE PROPHYLAXIS FOR HEALTH-CARE WORKERS - UNANSWERED QUESTIONS [J].
COX, RA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (01) :1-3
[7]   Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA) [J].
Eltringham, I .
JOURNAL OF HOSPITAL INFECTION, 1997, 35 (01) :1-8
[8]   Interpretive criteria for testing susceptibility of staphylococci to mupirocin [J].
Finlay, JE ;
Miller, LA ;
Poupard, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1137-1139
[9]   HIGH-LEVEL MUPIROCIN RESISTANCE IN STAPHYLOCOCCUS-AUREUS - EVIDENCE FOR 2 DISTINCT ISOLEUCYL-TRANSFER RNA-SYNTHETASES [J].
GILBART, J ;
PERRY, CR ;
SLOCOMBE, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (01) :32-38
[10]   MOLECULAR CHARACTERIZATION OF THE GENE ENCODING HIGH-LEVEL MUPIROCIN RESISTANCE IN STAPHYLOCOCCUS-AUREUS J2870 [J].
HODGSON, JE ;
CURNOCK, SP ;
DYKE, KGH ;
MORRIS, R ;
SYLVESTER, DR ;
GROSS, MS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (05) :1205-1208